Recruiting
Phase 1

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Sponsor:

University of Florida

Code:

NCT06254326

Conditions

Recurrent Oligodendroglioma

Progressive Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TTRNA-DC vaccines with GM-CSF

Autologous Hematopoietic Stem cells (HSCs)

TTRNA-xALT

Td vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information